GLP-1, 5mg/via CAS l87805-34-3
12 Inquiries
87805-34-3
Pharmaceutical Grade
99%
shenzhen
box
2026-04-20
Peptide products.
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceGLP-1 stimulates pancreatic β cells to secrete insulin as an incretin hormone. GLP-1 also has additional actions, including suppression of glucagon secretion, inhibition of gastric motility, and promotion of satiety.
GLP-1 was first identified in the early 1980s, following the cloning of the proglucagon gene. The biological activity of GLP-1 was investigated initially by using the N-terminal extended forms of GLP-1(1–37 and 1–36 amide). However, these forms were devoid of biological activity. In the late 1980s, bioactive GLP-1 peptides were purified from gut extracts and were identified to be GLP1(7–37) and GLP-1(7–36)-amide. In the current literature, the unqualified designation of GLP-1 corresponds to the truncated peptides.
Glucagon-Like Peptide I (GLP1) is an incretin hormone, which functions as ligand for GLP1 receptors (GLP1R). These receptors are expressed in renal and cardiovascular system, such as smooth muscle and endothelial cells.
Glucagon Like Peptide-1 is a single, non-glycosylated, polypeptide chain containing 30 amino acids and having a molecular mass of 3297.7 Dalton.The GLP-1 is purified by proprietary chromatographic techniques.Research & Reference NoteGLP-1, 5mg/via CAS l87805-34-3 is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Basic Info-
Product Name:
GLP-1
Other Name:HIS-ASP-GLU-PHE-GLU-ARG-HIS-ALA-GLU-GLY- THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU-PHE-ILE-ALA-TRP-LEU-VAL-LYS-GLY-ARGY-GLY;GLUCAGON-LIKE PEPTIDE I HUMAN;GLUCAGON-LIKE PEPTIDE-1, HUMAN;GLUCAGON-LIKE PEPTIDE I;GLUCAGON-LIKE PEPTIDE 1 (1-37) (HUMAN);GLUCAGON-LIKE PEPTIDE 1 (1-37) (HUMAN, BOVINE, GUINEA PIG, MOUSE, RAT);GLUCAGON-LIKE PEPTIDE 1 (1-37) (HUMAN, BOVINE, GUINEA PIG, MOUSE, RAT) TRIFLUOROACETATE SALT;GLP-1
CAS No.:87805-34-3
Molecular Formula:C186H275N51O59
InChIKeys:UKVFVQPAANCXIL-FJVFSOETSA-N
Molecular Weight:4169.48
EC Number:201-258-5
HScode:3504009000
Categories:
Characteristics-
Water Solubility:
Soluble to 5 mg/ml in water
Critical Temperature & Pressure:−20°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Peptide products.
-
Location:
No. 5, Guoxing Avenue, Lanshan District, Haikou City, Hainan Province. 2nd floor, Hainan Building. No. 206-102, Meilan District Digital Economy Park.
-
Average lead Time:
10
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
11-50
-
Year of Establishment:
2025
-
-
Inquiry History12 Inquiries
Country Product Purchase Quantity Date Posted 
China
GLP-1
1.00 KG Jul 17, 2026 
United States
GLP-1
1 KG Jun 5, 2025 
Australia
GLP-1
1.00 G Jul 17, 2026 
Philippines
GLP-1
15 MG Jul 14, 2026
United States
GLP 3
20 MG Feb 24, 2026
United States
99% Purity Reta Lyophilized Powder GLP-1 for Weight Loss
20 L Jan 8, 2026
Philippines
GLP-1
10 MG Jul 23, 2026
United States
glp1
30 MG Jul 1, 2026 
Thailand
GLP-3
300 MG Mar 10, 2026
United States
glp1
1 G Mar 10, 2026
United States
GLP-1
1 KG Feb 25, 2026
United States
glp1
1 KG Jan 5, 2026 Post an enquiry for this product
